Biopharma

CORRECTED: HHS abruptly terminates funding for Atlanta ...

The U.S. government continues to end contracts related to the $5 billion Project...

RFK Jr. promises autism answers by September. Prominent...

Robert F. Kennedy Jr. has vowed to find the root causes of autism by September. ...

STAT+: Device maker that helped UnitedHealth collect bi...

Semler Scientific has offered to pay the Department of Justice nearly $30 millio...

New research kindles excitement around stem cell therap...

Two studies published in Nature found stem cell-derived products can not only be...

Trump signals plan to address ‘pill penalty’ of drug pr...

The president’s executive order promising to lower pharmaceutical prices include...

HHS abruptly terminates funding for Atlanta biotech’s t...

The U.S. government continues to end contacts related to the $5 billion Project ...

Abbott plans to weather tariff storm with investments i...

Abbott said its network of 90 production sites around the world, plus $500 milli...

RFK Jr. targets HHS' vaccine safety reporting system, p...

The health secretary said he wants to automate and increase data collection thro...

Fierce Biotech Fundraising Tracker '25: Glycomine gathe...

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...

CDC vaccine panel review indicates potential changes to...

In the first meeting of the CDC's Advisory Committee on Immunization Practices u...

CDC panel mulls changes to COVID shot recommendations

The advisory committee, which met Tuesday for the first time since Robert F. Ken...

Trump throws pharma 'bread crumb' concession with call ...

As tariff threats and FDA staff cuts thrust the biopharma world into uncharted w...

STAT+: Harvard urges researchers to limit spending, cea...

Harvard University has urged researchers whose grants are frozen by the Trump ad...

With looming Trump tariffs, pharma companies demand cha...

Pharma companies are leveraging the Trump administration’s threat of tariffs on ...

PSUSA/00002774/202408

PSUSA/00002774/202408

GSK scolded after complainant flags ‘shocking error’ in...

GSK has been found guilty of bringing discredit on the pharma industry after a c...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim...

PSUSA/00000027/202407

PSUSA/00000027/202407

Opinion: STAT+: Promising signs for stem cell-based the...

Cell therapy development for Parkinson’s disease has been a marathon. Two new pa...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Scemblix, asciminib, D...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane,t...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Pirfenidone Viatris, p...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Plavix, clopidogrel, D...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Epysqli, Date of autho...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.